title: [Clinical application of transrectal ultrasonic therapy to nonbacterial prostatitis and prostatodynia cases which were resistant to conventional drug therapy].
abstract: A total of 25 patients with nonbacterial prostatitis and prostatodynia which were resistant to conventional drug therapy underwent 5 minutes course of transrectal ultrasonic therapy in association with application of 1% hydrocortisone acetate cream to the anterior rectal wall for consecutive 8 days. The efficacy of the treatment was evaluated only by comparison of symptom scores for subjective symptoms obtained before and after treatment. Excellent results, which were defined as more than 70% reduction of symptom scores after treatment, were obtained in 5 (27.8%) among 18 evaluable cases in which symptom scores before treatment were more than 4, good (40-69% reduction of scores) in 4 (22.2%), fair (10-39% reduction of scores) in 4 (22.2%) and poor (less than 10% reduction of scores) in 5 (27.8%). Because of good clinical efficacy and the absence of complication, transrectal ultrasonic therapy combined with hydrocortisone acetate cream application was thought to be useful for the treatment of nonbacterial prostatitis and prostatodynia cases which responded poorly to the conventional therapy.
authors.affiliation: Department of Urology, Nippon Medical School.
authors.forename: T
authors.initials: T
authors.lastname: Nishimura
authors.forename: K
authors.initials: K
authors.lastname: Horiuchi
authors.forename: M
authors.initials: M
authors.lastname: Oki
authors.forename: Y
authors.initials: Y
authors.lastname: Terashima
authors.forename: Y
authors.initials: Y
authors.lastname: Sugizawa
authors.forename: N
authors.initials: N
authors.lastname: Tuboi
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: M
authors.initials: M
authors.lastname: Akimoto
authors.forename: P C
authors.initials: PC
authors.lastname: Shi
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000031:analogs & derivatives; D008297:Male; D008875:Middle Aged; D059408:Pain Management; D011467:Prostate; D011472:Prostatitis / Q000628:therapy*; D014464:Ultrasonic Therapy / Q000295:instrumentation
chemical_list: C021650:hydrocortisone acetate; D006854:Hydrocortisone